All In Biotech

Drug Trial Radar · NCT03127267

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

Phase 3 Study to Compare the Efficacy and Safety of Masitinib in Combination With Riluzole Versus Placebo in Combination With Riluzole in the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)

Last checked: Nov 19, 2026Latest source record: Sep 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 495 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

495

Planned (sponsor's estimate)

Start

Feb 2, 2021

Primary completion

Dec 2027

Study completion Dec 2027

Sponsor

Lead sponsor
AB ScienceIndustry
Sponsor type
Industry
First posted
Apr 25, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 81 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective is to compare the efficacy and safety of masitinib in combination with riluzole versus matched placebo in combination with riluzole for the treatment of Amyotrophic Lateral Sclerosis (ALS).

Conditions

  • Amyotrophic Lateral Sclerosis

Interventions

  • Masitinib (6.0)Drug

    Masitinib (titration to 6.0 mg/kg/day)

  • RiluzoleDrug

    Riluzole 50 mg tablet, treatment per os

  • PlaceboDrug

    treatment per os

  • Masitinib (4.5)Drug

    Masitinib (titration to 4.5 mg/kg/day)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ALSFRS-RTime frame: 48 weeks

Locations

56 sites in 17 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama · Recruiting

  • University of Southern California

    Los Angeles, California · Recruiting

  • University of Kentucky

    Lexington, Kentucky · Recruiting

  • Johns Hopkins Medicine Brain Science Institute

    Baltimore, Maryland · Recruiting

  • Lahey Hospital and Medical Center

    Burlington, Massachusetts · Recruiting

  • University of Virginia Health System

    Charlottesville, Virginia · Recruiting

  • University Hospital Leuven (UZ Leuven)

    Leuven, Belgium · Recruiting

  • Bispebjerg Hospital

    Copenhagen, Denmark · Recruiting

  • CHU de Angers

    Angers, France · Recruiting

  • Groupe Hospitalier Pellegrin Tripode

    Bordeaux, France · Recruiting

  • Hôpital neurologique Pierre Wertheimer

    Bron, France · Recruiting

  • CHU Gabriel Montpied

    Clermont-Ferrand, France · Recruiting

  • CHU de Lille - Hopital Roger Salengro

    Lille, France · Recruiting

  • CHU de Limoges - Hôpital Dupuytren

    Limoges, France · Recruiting

  • CHU de Marseille - Hôpital de la Timone

    Marseille, France · Recruiting

  • CHRU de Montpellier - Gui de Chauliac

    Montpellier, France · Recruiting

  • CHU de Nancy - Hopital Central

    Nancy, France · Recruiting

  • CHU Hôpital Pasteur Nice

    Nice, France · Recruiting

  • CHRU de Tours - Hopital Bretonneau

    Tours, France · Recruiting

  • Department of Neurology, University of Ulm

    Ulm, Germany · Not yet recruiting

  • Athens Naval Hospital

    Athens, Greece · Recruiting

  • Eginition Hospital

    Athens, Greece · Recruiting

  • University General Hospital of Larissa

    Larissa, Greece · Recruiting

  • General University Hospital of Patras

    Rio, Greece · Recruiting

  • Hadassah University Hospital

    Jerusalem, Israel · Recruiting

  • Tel-Aviv Medical Center Hôpital Sourasky (ICHILOV)

    Tel Aviv, Israel · Recruiting

  • ASST degli Spedali Civili di Brescia

    Brescia, Italy · Recruiting

  • Centro Clinico NeMO Fondazione Serena Onlus

    Gussago, Italy · Recruiting

  • Clinico Nemo Center (Centro Clinico NeMO Milano)

    Milan, Italy · Recruiting

  • IRCCS Istituto Auxologico Italiano

    Milan, Italy · Recruiting

  • Istituti Clinici Scientifici Maugeri IRCCS

    Milan, Italy · Recruiting

  • San Raffaele Hospital (Ospedale San Raffaele)

    Milan, Italy · Recruiting

  • University Hospital Maggiore della Carita

    Novara, Italy · Recruiting

  • Azienda Ospedale-Università Padova

    Padova, Italy · Recruiting

  • IRCCS Mondino Foundation

    Pavia, Italy · Recruiting

  • University Hospital in Turin (Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino)

    Torino, Italy · Recruiting

  • Ospedale Civile Sant'Agostino - Estense

    Baggiovara, Modena, Italy · Recruiting

  • Oslo University Hospital HF Ullevål

    Oslo, Norway · Recruiting

  • Centrum Medyczne Neuromed

    Bydgoszcz, Poland · Recruiting

  • Hospital de Santa Maria

    Lisbon, Portugal · Recruiting

Showing 40 of 56 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.